Abe, H.; Okazawa, M.; Oyama, T.; Yamazaki, H.; Yoshimori, A.; Kamiya, T.; Tsukimoto, M.; Takao, K.; Sugita, Y.; Sakagami, H.;
et al. A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling. Medicines 2021, 8, 17.
https://doi.org/10.3390/medicines8040017
AMA Style
Abe H, Okazawa M, Oyama T, Yamazaki H, Yoshimori A, Kamiya T, Tsukimoto M, Takao K, Sugita Y, Sakagami H,
et al. A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling. Medicines. 2021; 8(4):17.
https://doi.org/10.3390/medicines8040017
Chicago/Turabian Style
Abe, Hideaki, Miwa Okazawa, Takahiro Oyama, Hiroaki Yamazaki, Atsushi Yoshimori, Takanori Kamiya, Mitsutoshi Tsukimoto, Koichi Takao, Yoshiaki Sugita, Hiroshi Sakagami,
and et al. 2021. "A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling" Medicines 8, no. 4: 17.
https://doi.org/10.3390/medicines8040017
APA Style
Abe, H., Okazawa, M., Oyama, T., Yamazaki, H., Yoshimori, A., Kamiya, T., Tsukimoto, M., Takao, K., Sugita, Y., Sakagami, H., Abe, T., & Tanuma, S.-i.
(2021). A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling. Medicines, 8(4), 17.
https://doi.org/10.3390/medicines8040017